Skip to main content

Published locations for FDA expands oral JAK abrocitinib to adolescents with AD

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA expands oral JAK abrocitinib to adolescents with AD

User login

  • Reset your password
  • /content/fda-expands-oral-jak-abrocitinib-adolescents-ad
  • /clinicianreviews/article/261169/atopic-dermatitis/fda-expands-oral-jak-abrocitinib-adolescents-ad
  • /edermatologynews/article/261169/atopic-dermatitis/fda-expands-oral-jak-abrocitinib-adolescents-ad
  • /familypracticenews/article/261169/atopic-dermatitis/fda-expands-oral-jak-abrocitinib-adolescents-ad
  • /internalmedicinenews/article/261169/atopic-dermatitis/fda-expands-oral-jak-abrocitinib-adolescents
  • /pediatricnews/article/261169/atopic-dermatitis/fda-expands-oral-jak-abrocitinib-adolescents-ad
  • /pediatrics/article/261169/atopic-dermatitis/fda-expands-oral-jak-abrocitinib-adolescents-ad
  • /internalmedicine/article/261169/atopic-dermatitis/fda-expands-oral-jak-abrocitinib-adolescents-ad
  • /dermatology/article/261169/atopic-dermatitis/fda-expands-oral-jak-abrocitinib-adolescents-ad
  • /familymedicine/article/261169/atopic-dermatitis/fda-expands-oral-jak-abrocitinib-adolescents-ad